This position paper has been written by the PRICOV-19 Consortium and is based on the published and upcoming scientific PRICOV-19 publications. The PRICOV-19 Consortium has validated this position statement. The EQuiP Council endorsed it following a discussion by conference attendees at the 62nd EQuiP conference in Dublin on 12th May 2023.
The PRICOV-19 study was set up in Ghent, Belgium, in collaboration with EQuiP during the COVID-19 Pandemic in 2020.
All credit for this position statement belongs to the 48 partnering institutions of the PRICOV-19 Research Consortium and the individual PRICOV-19 consortium researchers.
The Consortium wishes to express its deep gratitude to EQuiP for their support of PRICOV-19, and for their efforts to validate and disseminate the lessons learned.
For more information, please see the PRICOV-19 Research Consortium website: https://pricov19study.ugent.
Click here to access full statement in pdf format.
Published on 17 May 2023.